Prophylactic administration of recombinant IL-10 in the caerulein–1-day model of AP has been shown to significantly reduce serum amylase and lipase levels with moderate reduction in edema and inflammation, as well as with remarkable improvement in necrosis, on histology (29). Here, IL10 is linked to alkaline phosphatase measurement.